Published in Biotech Law Weekly, May 26th, 2006
According to a report from Taiwan, "This study was conducted to investigate the role of oxidized low-density lipoprotein (LDL) in monocyte/mononuclear cell (MNC) activation during atherogenesis. First, the activity of MNCs was studied in patients with coronary artery disease (CAD)."
J.W. Chen and colleagues at National Yang-Ming University explained, "Compared to normal subjects, phorbol 12-myristate 13-acetate (PMA)-stimulated reactive...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.